The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids
- PMID: 1676210
The hairless mouse as a model for study of local and systemic atrophogenic effects following topical application of corticosteroids
Abstract
The hairless mouse has been used as a model to distinguish between local and systemic atrophogenic effects of topical steroids. Hydrocortisone-17-butyrate, betamethasone-17-valerate, budesonide and clobetasol-17-propionate were applied topically daily for 21 days. Skinfold thickness and dermal DNA synthesis of treated and untreated skin were evaluated as parameters of local and systemic atrophogenicity. Further, body weight gain and thymus weight were assessed as markers of systemic activity. With respect to local effects, skin thickness and dermal DNA synthesis both proved to be good parameters. Of the systemic parameters, thymic involution and body weight gain paralleled quite well the skin thinning on the untreated side. The results confirmed the potency differences of the steroids. Furthermore, they emphasize the usefulness of the hairless mouse to assess the relative safety with respect to local and systemic side effects of chronically applied topical corticosteroids.
Similar articles
-
Effects of a multilamellar emulsion on glucocorticoid-induced epidermal atrophy and barrier impairment.J Dermatol. 2006 Feb;33(2):80-90. doi: 10.1111/j.1346-8138.2006.00018.x. J Dermatol. 2006. PMID: 16556273
-
Identification of novel in vitro test systems for the determination of glucocorticoid receptor ligand-induced skin atrophy.Skin Pharmacol Physiol. 2010;23(3):139-51. doi: 10.1159/000270386. Epub 2009 Dec 23. Skin Pharmacol Physiol. 2010. PMID: 20051715
-
The effects of topical and systemic glucocorticosteroids on DNA synthesis in different tissues of the hairless mouse.Br J Dermatol. 1981 Nov;105(5):517-20. doi: 10.1111/j.1365-2133.1981.tb00794.x. Br J Dermatol. 1981. PMID: 7295568
-
[Topical corticosteroids in dermatology--advantages and side effects].Przegl Lek. 2002;59(3):170-4. Przegl Lek. 2002. PMID: 12184032 Review. Polish.
-
Topical application of calcipotriene and corticosteroids: combination regimens.J Am Acad Dermatol. 1997 Sep;37(3 Pt 2):S55-8. J Am Acad Dermatol. 1997. PMID: 9344186 Review.
Cited by
-
Inhibition of glucocorticoid-induced epidermal and dermal atrophy with KH 1060--a potent 20-epi analogue of 1,25-dihydroxyvitamin D3.Br J Pharmacol. 1994 Oct;113(2):439-44. doi: 10.1111/j.1476-5381.1994.tb17008.x. Br J Pharmacol. 1994. PMID: 7834193 Free PMC article.
-
Skinfold thickness can predict elastosis in hairless mice.Arch Dermatol Res. 1996 Oct;288(11):722-4. doi: 10.1007/BF02505285. Arch Dermatol Res. 1996. PMID: 8931878 No abstract available.
-
Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases.Br J Pharmacol. 2009 Oct;158(4):1088-103. doi: 10.1111/j.1476-5381.2009.00238.x. Epub 2009 May 6. Br J Pharmacol. 2009. PMID: 19422381 Free PMC article.